Have Thoracic Endografting Outcomes Improved Since US Food and Drug Administration Approval?

Annals of Thoracic Surgery - Netherlands
doi 10.1016/j.athoracsur.2011.01.037
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Transparency and Dermatologic Device Approval by the US Food and Drug Administration

JAMA Dermatology
DermatologyMedicine
2018English

Inclusion of Training Patients in US Food and Drug Administration Premarket Approval Cardiovascular Device Studies

Archives of Internal Medicine
2011English

Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017

JAMA network open
Medicine
2020English

Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2018English

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration

JAMA network open
Medicine
2019English

Time From US Food and Drug Administration Approval to Publication of Data for Cancer Drugs: A Comparison of First and Subsequent Approvals

Blood Cancer Journal
OncologyHematology
2017English

A Randomized Trial Testing US Food and Drug Administration “Breakthrough” Language

JAMA Internal Medicine
Internal Medicine
2015English

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy